Farnum Rhonda (CIK 1898490) reported 26 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell TBPH (124,414 shares), Sell TBPH (89,062 shares), Sell TBPH (3,329 shares), Sell TBPH (3,328 shares), Sell TBPH (6,657 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 124,414 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 89,062 | $0 |
| 2026-09-17 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,329 | $56,707 |
| 2026-09-17 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,328 | $56,690 |
| 2026-09-17 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 6,657 | $113,397 |
| 2026-08-24 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 5,667 | $96,056 |
| 2026-06-17 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,329 | $54,562 |
| 2026-06-17 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,328 | $54,513 |
| 2026-06-17 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 6,657 | $109,108 |
| 2026-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 5,678 | $93,971 |
| 2026-04-03 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Buy | 18,750 | $0 |
| 2026-03-18 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 15,534 | $217,476 |
| 2026-03-18 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 7,767 | $108,117 |
| 2026-03-18 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 7,766 | $108,103 |
| 2026-02-24 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 13,929 | $273,844 |
| 2025-12-05 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 7,767 | $145,631 |
| 2025-12-05 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 7,766 | $145,612 |
| 2025-12-05 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 15,534 | $291,262 |
| 2025-11-24 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 9,060 | $162,174 |
| 2025-08-22 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 9,096 | $121,795 |
| 2025-07-16 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 682 | $7,768 |
| 2025-07-16 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 5,318 | $60,572 |
| 2025-07-16 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 4,000 | $45,560 |
| 2025-06-04 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 24,000 | $264,000 |
| 2025-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | Sell | 9,120 | $86,184 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24